Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Chesebro

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
Circulation|October 23, 1997
Direct thrombin inhibition superior to heparin during and after thrombolysis: dose, duration, and drugJ H Chesebro
Seminars in Hematology|December 17, 1997
Treatment of arterial thrombosis with low molecular weight heparinsJ H Chesebro
Thrombosis Research. Supplement|January 1, 1990
Effect of dipyridamole and aspirin on vein graft patency after coronary bypass operationsJ H Chesebro
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1985
Coronary artery bypass grafting. A model for the understanding of the progression of atherosclerotic disease and the role of pharmacological interventionV Fuster, J H Chesebro
European Heart Journal|July 1, 1995
Aspirin for primary prevention of coronary diseaseV Fuster, J H Chesebro
International Journal of Cardiology|January 1, 1983
Platelets and platelet-inhibitor drugs in aortocoronary vein bypass operationsJ H Chesebro, V Fuster
Circulation|May 1, 1991
Dynamic thrombosis and thrombolysis. Role of antithrombinsJ H Chesebro, V Fuster
Mayo Clinic Proceedings|April 1, 1981
Series on pharmacology in practice. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. III. Management of arterial thromboembolic and atherosclerotic disease (third of three parts)V Fuster, J H Chesebro
The New England Journal of Medicine|October 16, 1986
Mechanisms of unstable anginaV Fuster, J H Chesebro
Mayo Clinic Proceedings|March 1, 1981
10. Antithrombotic therapy: role of platelet-inhibitor drugs. II. Pharmacologic effects of platelet-inhibitor drugs (second of three parts)V Fuster, J H Chesebro
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
Circulation|October 23, 1997
Direct thrombin inhibition superior to heparin during and after thrombolysis: dose, duration, and drugJ H Chesebro
Seminars in Hematology|December 17, 1997
Treatment of arterial thrombosis with low molecular weight heparinsJ H Chesebro
Thrombosis Research. Supplement|January 1, 1990
Effect of dipyridamole and aspirin on vein graft patency after coronary bypass operationsJ H Chesebro
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1985
Coronary artery bypass grafting. A model for the understanding of the progression of atherosclerotic disease and the role of pharmacological interventionV Fuster, J H Chesebro
European Heart Journal|July 1, 1995
Aspirin for primary prevention of coronary diseaseV Fuster, J H Chesebro
International Journal of Cardiology|January 1, 1983
Platelets and platelet-inhibitor drugs in aortocoronary vein bypass operationsJ H Chesebro, V Fuster
Circulation|May 1, 1991
Dynamic thrombosis and thrombolysis. Role of antithrombinsJ H Chesebro, V Fuster
Mayo Clinic Proceedings|April 1, 1981
Series on pharmacology in practice. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. III. Management of arterial thromboembolic and atherosclerotic disease (third of three parts)V Fuster, J H Chesebro
The New England Journal of Medicine|October 16, 1986
Mechanisms of unstable anginaV Fuster, J H Chesebro
Mayo Clinic Proceedings|March 1, 1981
10. Antithrombotic therapy: role of platelet-inhibitor drugs. II. Pharmacologic effects of platelet-inhibitor drugs (second of three parts)V Fuster, J H Chesebro
Pageof 21